Equities

Medinet Co Ltd

2370:TYO

Medinet Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)41.00
  • Today's Change-1.00 / -2.38%
  • Shares traded2.14m
  • 1 Year change-10.87%
  • Beta2.2433
Data delayed at least 20 minutes, as of Nov 26 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Sep 30 2024202420232022
OPERATIONS
Net income(1273)(1434)(1249)
Depreciation/depletion115103106
Non-Cash items(63)54(67)
Cash taxes paid, supplemental4.205.355.45
Cash interest paid, supplemental0.030.060.10
Changes in working capital(49)1348
Total cash from operations(1271)(1264)(1161)
INVESTING
Capital expenditures(59)(85)(41)
Other investing and cash flow items, total1258820
Total cash from investing653.27(20)
FINANCING
Financing cash flow items0.0027(2.41)
Total cash dividends paid------
Issuance (retirement) of stock, net1,4621,1321,591
Issuance (retirement) of debt, net(1.53)(1.99)(3.39)
Total cash from financing1,4611,1581,585
NET CHANGE IN CASH
Foreign exchange effects--00
Net change in cash255(103)403
Net cash-begin balance/reserved for future use4,3964,4994,096
Net cash-end balance/reserved for future use4,6514,3964,499
SUPPLEMENTAL INCOME
Depreciation, supplemental115103106
Cash interest paid, supplemental0.030.060.10
Cash taxes paid, supplemental4.205.355.45
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.